Prentiss Smith & Co’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-26,714
Closed -$3.16M 77
2021
Q1
$3.16M Sell
26,714
-45,546
-63% -$5.34M 1.62% 26
2020
Q4
$8.46M Sell
72,260
-1,655
-2% -$182K 4.04% 5
2020
Q3
$7.68M Sell
73,915
-2,359
-3% -$237K 4% 6
2020
Q2
$6.99M Sell
76,274
-302
-0.4% -$29K 4.32% 5
2020
Q1
$6.91M Buy
76,576
+24,933
+48% +$2.65M 4.79% 4
2019
Q4
$5.86M Sell
51,643
-965
-2% -$106K 3.76% 11
2019
Q3
$5.71M Sell
52,608
-31,085
-37% -$3.24M 3.83% 9
2019
Q2
$8.15M Buy
83,693
+1,618
+2% +$148K 5.32% 3
2019
Q1
$7.47M Buy
82,075
+8,340
+11% +$746K 4.75% 6
2018
Q4
$6.71M Sell
73,735
-116
-0.2% -$10.8K 4.22% 8
2018
Q3
$7.26M Sell
73,851
-701
-0.9% -$64.8K 4.14% 10
2018
Q2
$6.38M Sell
74,552
-4,683
-6% -$391K 3.86% 13
2018
Q1
$6.36M Buy
79,235
+73,665
+1,323% +$6.08M 3.33% 14
2017
Q4
$450K Buy
5,570
+5,521
+11,267% +$442K 0.22% 55
2017
Q3
$4K Buy
+49
New +$4.07K ﹤0.01% 224
2017
Q1
Sell
-141
Closed -$10K 260
2016
Q4
$10K Buy
+141
New +$11.1K 0.01% 203
2016
Q2
Sell
-91
Closed -$7K 296
2016
Q1
$7K Hold
91
﹤0.01% 250
2015
Q4
$7K Hold
91
﹤0.01% 261
2015
Q3
$6K Hold
91
﹤0.01% 253
2015
Q2
$7K Hold
91
﹤0.01% 225
2015
Q1
$7K Hold
91
﹤0.01% 251
2014
Q4
$7K Hold
91
﹤0.01% 257
2014
Q3
$6K Buy
+91
New +$5.79K ﹤0.01% 202

Other funds holding MDT

Prentiss Smith & Co's MDT Position: Q2 2021 in Review

Prentiss Smith & Co sold out of Medtronic (MDT) in Q2 2021, closing a stake of 26,714 shares — an estimated $3.16M sold.

Prentiss Smith & Co first reported a position in MDT in Q3 2014 and held it in 23 quarters. The position peaked at $8.46M in Q4 2020. 2,003 funds tracked by Wall St. Rank hold MDT as of Q2 2021.

  • Prentiss Smith & Co reported no remaining Medtronic position as of Q2 2021 after selling out during the quarter.
  • Prentiss Smith & Co sold 26,714 Medtronic shares in Q2 2021, an estimated $3.16M.
  • Prentiss Smith & Co first reported a position in Medtronic in Q3 2014 and held it in 23 quarters.
  • Prentiss Smith & Co's Medtronic position peaked at $8.46M in Q4 2020.
  • 2,003 funds tracked by Wall St. Rank held Medtronic as of Q2 2021.

Based on Prentiss Smith & Co's 13F filing for Q2 2021, filed 15 Jul 2021.